OEMINE P.S.O. 180 CP
Food supplement declared in France, declaration No 2018-6-256
OEMINE P.S.O. 180 CP, from PHYBIO PHARMA, is a food supplement declared in France. Status: withdrawn from the market on 29 November 2025. Main ingredients: Ascophyllum nodosum 37 mg per day, Lécithine. None of the rules we check flags an issue with its declared composition.
- Brand
- OEMINE
- Food business operator placing the product on the market
- PHYBIO PHARMA
- Status
- Withdrawn from the market on 29 November 2025
- Form
- Tablet
- Daily dose
- 8 comprimés
- Directions for use
- 4 comprimés matin et soir
- Objectives stated by the manufacturer (these are not authorised claims)
- Skin
Declaration 289160, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Ascophyllum nodosum (L.) Le Jolis | Thalle | Poudre (de plantes séchées ou broyées) | 37 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Lécithine | not declared |
Additives
E341, E460, E414, E470b
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
contre indiqué chez les personnes allergiques aux produits marins : poissons, mollusques et fruits de mer.
Regulatory points
- Information
Withdrawn from the market on 29 November 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Lécithine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : OEMINE
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “OEMINE P.S.O. 180 CP: composition and regulation”, https://compoatlas.com/en/supplements/products/289160-oemine-p-s-o-180-cp, updated 15 November 2026.